Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic cells as shepherds of T cell immunity in cancer
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 92

Showing 26-50 of 92 citing articles:

Intratumoral administration of the immunologic adjuvant AS01Bin combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma
Jens Tijtgat, Xenia Geeraerts, Anaïs Boisson, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008148-e008148
Open Access | Times Cited: 4
ALCAM-mediated cDC1 CD8 T cells interactions are suppressed in advanced lung tumors
Luciano Gastón Morosi, Giulia Maria Piperno, Lucía López, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Lipid Nanoparticle‐mRNA Engineered Dendritic Cell Based Adoptive Cell Therapy Enhances Cancer Immune Response
R.K. Das, Xinying Ge, Fan Fei, et al.
Small Methods (2024)
Open Access | Times Cited: 4
Hepatocellular Carcinoma Immunotherapy: Predictors of Response, Issues, and Challenges
Alessandro Rizzo, Oronzo Brunetti, Giovanni Brandi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11091-11091
Open Access | Times Cited: 4
Strategies for engineering biomimetic materials for tumor therapy
Zhaoyu Ma, Kai Zhang, Yanli Zhao
Matter (2025) Vol. 8, Iss. 1, pp. 101899-101899
Closed Access
Recent developments in myeloid immune modulation in cancer therapy
Sepideh Parvanian, Xinying Ge, Christopher Garris
Trends in cancer (2025)
Closed Access
Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis
Wenxiang Hong, Hongbo Ma, Zhaoxu Yang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back
Annapaola Mariniello, Maxime Borgeaud, Marc Weiner, et al.
BioDrugs (2025)
Open Access
Hydrotalcites-Induced Pyroptosis Combined with Toll-Like Receptor Activation Elicited Dual Stimulation of Innate and Adaptive Immunity
Jie Wu, Zhicheng Liu, Li Wang, et al.
ACS Nano (2025)
Closed Access
Recent Advances in the Development and Efficacy of Anti-Cancer Vaccines—A Narrative Review
Kajetan Kiełbowski, Paulina Plewa, Jan Zadworny, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 237-237
Open Access
Engineering colloidal systems for cell manipulation, delivery, and tracking
Olga A. Sindeeva, Zhanna V. Kozyreva, Arkady S. Abdurashitov, et al.
Advances in Colloid and Interface Science (2025) Vol. 340, pp. 103462-103462
Closed Access
Beyond CCR7: dendritic cell migration in type 2 inflammation
Audrey Meloun, Beatriz León
Frontiers in Immunology (2025) Vol. 16
Open Access
Immuno-cell metabolic changes in HIV-1 infection
Xu Li, Yue Jiang, Xuexing Zheng, et al.
Infectious Diseases & Immunity (2025)
Open Access
Enhanced Tumor Ablation and Immune Activation Via Irreversible Electroporation and Functionalized Vermiculite Nanosheets
Runtan Li, Gaoli Niu, Yaoguang She, et al.
Small (2025)
Closed Access
Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma
Hongyan Zhang, Jingyi Huang, Yujie Li, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma
Athanasios Seretis, Lukas Amon, Christoph H. Tripp, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 346-346
Open Access
Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy
Laura Rodríguez, Roberto M. Amadio, Giulia Maria Piperno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010547-e010547
Open Access
Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy
Xiaomeng Guo, Junqiang Bai, Xinmiao Wang, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114576-114576
Closed Access
A silence catalyst: CCL5-mediated intercellular communication in cancer
Wei‐Ting Hu, Min Li, Peijun Ma, et al.
Archives of Toxicology (2025)
Closed Access
Novel Strategies in Breast Cancer Management: from Treatment to Long-term Remission
S Habibi, Shabbou Bahramian, Saeedeh Zare Jalise, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104715-104715
Closed Access
Gallium‐Magnesium Layered Double Hydroxide for Elevated Tumor Immunotherapy Through Multi‐Network Synergistic Regulation
Jia Tan, Binbin Ding, Hao Chen, et al.
Advanced Materials (2025)
Closed Access
STING Inhibitors and Degraders: Potential Therapeutic Agents in Inflammatory Diseases
Kerong Wu, Yiwen Xu, Peizhao Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 291, pp. 117632-117632
Closed Access
The role of ion channels in the regulation of dendritic cell function
Shibin Zhou, Lanlan Zhong, Yi-Lan Wu, et al.
Cell Calcium (2025) Vol. 128, pp. 103031-103031
Closed Access
Reversing hypoxia-induced immune evasion in tumors to enhance cancer immunotherapy
Qiuting Sun, Guisong Shan, Wanrong Wang, et al.
Journal of Controlled Release (2025), pp. 113745-113745
Closed Access

Scroll to top